obesity drugs glp-1 news today cleared of suicide warning New GLP-1 Pill Foundayo (Orforglipron)

This is the most straightforward pathway to reduced effectiveness

I'm here on the ground at the 2025 HIMSS Global Health Conference and Exhibition, where health care and technology leaders are touting their latest and greatest innovations

What makes this approval especially interesting is convenience

The Medicare pivot of 2026 For most of the drugs history, Medicare was legally barred from covering weight-loss medications a rule inherited from the 2003 legislation that created Medicare Part D, when the memory of fen-phen and other appetite suppressants made lawmakers wary

It depends on your plan and whether you have any copays or deductibles